ALNY
Alnylam Pharmaceuticals Inc
Price:  
159.73 
USD
Volume:  
2,162,127.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam Intrinsic Value

-17.20 %
Upside

What is the intrinsic value of Alnylam?

As of 2026-11-17, the Intrinsic Value of Alnylam Pharmaceuticals Inc (ALNY) is 132.30 USD. This Alnylam valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 159.73 USD, the upside of Alnylam Pharmaceuticals Inc is -17.20%.

The range of the Intrinsic Value is 91.15 - 238.34 USD

Is Alnylam undervalued or overvalued?

Based on its market price of 159.73 USD and our intrinsic valuation, Alnylam Pharmaceuticals Inc (ALNY) is overvalued by 17.20%.

159.73 USD
Stock Price
132.30 USD
Intrinsic Value
Intrinsic Value Details

Alnylam Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 91.15 - 238.34 132.30 -17.2%
DCF (Growth 10y) 207.59 - 540.92 301.09 88.5%
DCF (EBITDA 5y) 170.28 - 276.42 209.70 31.3%
DCF (EBITDA 10y) 290.98 - 507.97 371.91 132.8%
Fair Value 508.48 - 508.48 508.48 218.34%
P/E 86.19 - 432.82 259.76 62.6%
EV/EBITDA 64.13 - 151.78 94.21 -41.0%
EPV (6.57) - (6.25) (6.41) -104.0%
DDM - Stable 156.25 - 504.55 330.40 106.8%
DDM - Multi 82.34 - 210.85 118.93 -25.5%

Alnylam Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 21,394.24
Beta 0.80
Outstanding shares (mil) 133.94
Enterprise Value (mil) 22,387.38
Market risk premium 4.60%
Cost of Equity 10.37%
Cost of Debt 5.73%
WACC 9.85%